Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Clinical trial NCT05489887 · RECRUITING
Trial details
- NCT number
- NCT05489887
- Sponsor
- Giselle Sholler
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2029-09-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.